medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Using next generation matrices to estimate the proportion of cases that
are not detected in an outbreak
H Juliette T Unwin1, Anne Cori1, Natsuko Imai1, Katy A. M. Gaythorpe1, Sangeeta Bhatia1,
Lorenzo Cattarino1, Christl A. Donnelly1,2, Neil M. Ferguson1 and Marc Baguelin1,3

1

MRC Centre for Global Infectious Disease Analysis; and the Abdul Latif Jameel Institute for

Disease and Emergency Analytics (J-IDEA), School of Public Health, Imperial College London.
2

Department of Statistics, University of Oxford (CAD)

3

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical

Medicine, London, UK (MB)
Keywords: Mathematical modelling, Disease Outbreaks; Disease Transmission, Infectious;
Epidemiological Methods
Abbreviations: New Zealand, NZ; next generation matrices, NGM; basic reproduction number,

ğ‘…! ; severe acute respiratory syndrome coronavirus 2, SARS-CoV-2.
Contact tracing, where exposed individuals are followed up to break ongoing transmission
chains, is a key pillar of outbreak response for many infectious disease outbreaks, such as
Ebola and SARS-CoV-2. Unfortunately, these systems are not fully effective, and cases can
still go undetected as people may not know or remember all of their contacts or contacts
may not be able to be traced. A large proportion of undetected cases suggests poor contact
tracing and surveillance systems, which could be a potential area of improvement for a
disease response. In this paper, we present a novel method for estimating the proportion of
cases that are not detected during an outbreak. Our method uses next generation matrices
that are parameterized by linked contact tracing and case line-lists. We use this method to
investigate the proportion of undetected cases in two case studies: the SARS-CoV-2
outbreak in New Zealand during 2020 and the West African Ebola outbreak in Guinea
during 2014. We estimate that only 6% of SARS-CoV-2 cases were not detected in New
1
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Zealand (95% credible interval: 1.31 â€“ 16.7%), but over 60% of Ebola cases were not
detected in Guinea (95% credible interval: 15 - 90%).
-------------------------------------------------------------------------------------------------------------There are many non-pharmaceutical interventions for controlling infectious disease
epidemics. Some control measures, such as case isolation and safe and dignified burials for
Ebola, avoid secondary cases but others, such as contact tracing, avoid tertiary cases.
Measures, which avoid secondary cases, are most effective when tertiary cases are also
avoided and all (or nearly all) cases are identified so that interventions can be targeted to
those who are infected and those who have been exposed (1). If contact tracing is
implemented well, contacts of known cases can take precautions to reduce onward
transmission by limiting their contacts and isolating quickly on symptom onset (2â€“4).
However, if many cases are not detected, outbreaks can grow rapidly as undetected cases
usually infect more people than detected cases (5).
Cases or deaths may not be reported for a variety of reasons (6). Poor availability of tests at
the start of an outbreak of an emerging pathogen, such as SARS-CoV-2, may mean that
those with symptoms cannot be diagnosed (7). Asymptomatic individuals may also not
know they are infected unless tested for other reasons, such as through contact tracing or
for routine medical care (8). Undetected cases are not unique to COVID-19 and underreporting is common in Ebola outbreaks due to barriers to accessing health care and limited
hospital capacity meaning many cases are not hospitalized and are less likely to be reported
(9). Many patients may not seek health care due to mistrust and if they die, may be buried
without notification, leading again to those cases being missed from official lists (10).
Infectious disease analysis and modelling are important tools for managing epidemics and
can help provide quantitative evidence and situational awareness to government and public
health responses (11). The importance of such analyses has been highlighted by the
response to the COVID-19 pandemic, which has been, to a large extent, informed by
epidemic modelling e.g. (12â€“14). However, these models often require robust case data to
2

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

make accurate transmission predictions. Over time attempts have been made to account for
under-reporting in models. Some models assume perfect reporting (15,16), however, this
can lead to an underestimation of the infection rate (6). Other methods assume a constant
under-reporting rate (17) or use data augmentation techniques (6). More recently, many
models have switched to using death data, which was believed to be more reliable than case
data, because it is more likely consistent over time and between countries (13). This is
especially important for methods which are robust to constant under-reporting.
We propose using a quasi-Bayesian next generation matrix (NGM) approach in this paper
to estimate the proportion of cases that are not detected in an outbreak. This method is not
disease specific and is simple to implement from contact tracing and surveillance data. The
calculation can also be repeated throughout the outbreak to provide time varying estimates.
We present two applications of our method: the SARS-CoV-2 outbreak in New Zealand in
2020 and the 2014 Ebola epidemic in Guinea.

METHODS
NGMs are often used to calculate the basic reproduction number (the average number of
secondary infections generated by a primary infection in a large fully susceptible
population), ğ‘…! , from a finite number of discrete categories that are based on
epidemiologically relevant traits in the population, such as infected individuals at different
stages of infection (e.g. exposed and infectious) or with different characteristics (e.g. age).
The NGM is a matrix which quantifies the number of secondary infections generated in
each category by an infected individual in a given category. ğ‘…! is defined as the dominant
eigenvector of this matrix (18,19). Here, we stratify infected individuals using information
about their contact tracing status and whether they were being followed up at the time of
symptom onset to assign infection pathways and construct our NGM. We identify three
types of cases: i) cases that are not detected (ND), ii) cases that are detected but not under
active surveillance (NAS), and (iii) cases that are detected and under active surveillance
3

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

(AS). Contact follow-up or surveillance takes different forms for different diseases; for
Ebola, a contact under active surveillance would be undergoing in-person follow-up for 21
days after their last interaction with the case (20), whereas for COVID-19, a contact under
active surveillance would have been notified by contact tracers, or through a mobile phone
application, and asked to self-isolate for up to 10 days (21,22).
Formulation of the NGM
For contact tracing to be fully effective, the parent (or primary) case needs to be diagnosed
and, if positive, all their contacts placed under active surveillance. The parent case
therefore needs to know and remember everyone they have been in close contact with
whilst they have been infectious and for these contacts to be contacted. Despite a contact
being recalled and reported, they may not be under active surveillance if they cannot be
identified due to missing or incorrect contact details or evasion from contact tracers. We
assume in our model that: i) cases that are not detected and those cases detected but not
under active surveillance have the same effective reproduction number (R) and therefore on
average, infect the same number of secondary cases; and ii) contacts under surveillance
who become cases have a lower effective reproduction number (scaled by ğ›¼) because they
are rapidly isolated after the onset of symptoms. We define ğœ™ as the proportion of contacts
recalled, ğ›¾ as the proportion of contacts actively under surveillance, and ğœ‹ as the proportion
of cases detected or â€œre-capturedâ€ by community surveillance
We identify 12 pathways through which individuals can become infected by three different
types of cases (Figure 1). These pathways are described as follows:
1.

A case that was detected (with probability ğœ‹), who was infected by a case that was not
detected and was therefore not under active surveillance.

2.

A case that was not detected (with probability 1-ğœ‹), who was infected by a case that
was not detected and was therefore not under active surveillance.

4

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

3.

A case that was detected (with probability ğœ‹), who was infected by a case that was
detected but not under surveillance, was correctly recalled as a contact (with
probability ğœ™) and was under active surveillance (with probability ğ›¾).

4.

A case that was detected (with probability ğœ‹), who was infected by a case that was
detected but that was not under surveillance, was correctly recalled as a contact (with
probability ğœ™) but was not under surveillance (with probability 1- ğ›¾).

5.

A case that was not detected (with probability 1-ğœ‹) case, who was infected by a case
that was detected but not under surveillance, was correctly recalled (with probability
ğœ™) but was not under surveillance (with probability 1- ğ›¾).

6.

A case that was detected (with probability ğœ‹) case, who was infected by a case that
was detected but not under surveillance, that was not recalled (probability 1-ğœ™).

7.

A case that was not detected (with probability 1-ğœ‹) case, who was infected by a case
that was detected but not under surveillance, that was not recalled (probability 1-ğœ™).

8.

A case that was detected (with probability ğœ‹), who was infected by a case that was
detected and under surveillance, was correctly recalled (with probability ğœ™) and was
under surveillance (with probability ğ›¾).

9.

A case that was detected (with probability ğœ‹) case, who was infected by a case that
was detected and under surveillance, was correctly recalled (with probability ğœ™) but
was not under surveillance (with probability 1- ğ›¾).

10. A case that was not detected (with probability 1-ğœ‹), who was infected by a case that
was detected and under surveillance, was correctly recalled (with probability ğœ™) but
was not under surveillance (with probability 1- ğ›¾).
11. A case that was detected (with probability ğœ‹), who was infected by a case that was
detected and under surveillance, that was not recalled (with probability 1-ğœ™).
12. A case that was not detected (with probability 1-ğœ‹) case, who was infected by a case
that was detected and under surveillance, that was not recalled (with probability 1-ğœ™).

5

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Seven of our twelve pathways result in detected cases. The cases from pathways 3, 4, 8, and
9 are individuals on contact lists who are detected as cases whereas, the cases from
pathways 1, 6, and 11 are de novo cases that are not on any contact tracing list, but which
are detected via other routes such as attending a health care unit. The cases from pathways
3 and 8 are contacts who were under surveillance at the time of symptom onset, while those
from pathways 4 and 9 were not under surveillance at onset. The cases resulting from the
pathways 2, 5, 7, 10 and 12 are not detected by the surveillance system. We use the
notation FX to denote the probability of a case stemming from pathway X, for example F1
equals ğ‘…ğœ‹.
If ğ‘" = [ğ‘ğ·" , ğ‘ğ´ğ‘†" , ğ´ğ‘†" ]# is a vector of the number of each type of case for generation ğ‘›,
the dynamics of the model is given by:
ğ‘"$% = ğ´ğ‘" ,

(1)

where ğ›¢ is our NGM that represent the potential transitions from one generation of cases to
the next
1âˆ’ğœ‹
ğ´ = ğ‘…8 ğœ‹
0

(1 âˆ’ ğœ‹)(1 âˆ’ ğ›¾ğœ™)
ğœ‹(1 âˆ’ ğ›¾ğœ™)
ğ›¾ğœ™

ğ›¼(1 âˆ’ ğœ‹)(1 âˆ’ ğ›¾ğœ™)
ğ›¼ğœ‹(1 âˆ’ ğ›¾ğœ™) ; .
ğ›¼ğ›¾ğœ™

(2)

From the eigenvalues of this NGM, we can calculate the proportion of each of the three
types cases (ND, NAS and AS), see Supplementary Information (SI) A. In the limit as ğ‘›
goes to infinity, an equilibrium is reach and the proportion of cases that are not detected,
ğœ‡&' , can be calculated as:
ğœ‡!"

= lim

#â†’% ğ‘ğ·#

ğ‘ğ·#
+ ğ‘ğ´ğ‘†# + ğ´ğ‘†#

(âˆ’1 + ğœ‹)-1 + ğ›¼(âˆ’2 + ğ›¾ğœ™) âˆ’ ğœ‹ğ›¾ğœ™ + 2âˆ’2ğœ‹(1 + ğ›¼(âˆ’2 + ğ›¾ğœ™))ğ›¾ğœ™ + ğœ‹ & ğ›¾ğœ™]& + (âˆ’1 + ğ›¼ğ›¾ğœ™)& 4
=
.
2(ğ›¼ âˆ’ 1)

Linking our model to contact tracing and surveillance system data

6

(3)

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Cases are often recorded in line-lists during disease outbreaks, where dates of testing,
symptom onset and hospitalization are recorded alongside information about the age and
sex of the patient. When case lists are linked to contact lists, we can derive two ratios with
which we parameterize our NGM. We define ğ‘Ÿ% as the ratio of cases who were contacts but
not under surveillance versus the cases who were contacts and under surveillance and ğ‘Ÿ( as
the ratio of de novo cases (cases that were not known contacts) versus detected cases that
were contacts and under surveillance.
Following the pathways in Figure 1, we expand ğ‘Ÿ% (the ratio of cases who were contacts but
not under surveillance versus the cases who were contacts and under surveillance) as
)*$)+

?),$)-@. At the equilibrium of the surveillance process (SIA), we have ğ‘ğ·" = ğœ‡&' ğ¶" ,
ğ‘ğ´ğ‘†" = ğœ‡&./ ğ¶" and ğ´ğ‘†" = ğœ‡./ ğ¶" , where ğ¶" = ğ‘ğ·" + ğ‘ğ´ğ‘†" + ğ´ğ‘†" is the total number of
cases at generation ğ‘›, ğœ‡&./ is the proportion of cases not under active surveillance and ğœ‡./
is the proportion of cases under active surveillance. Therefore,
ğ‘Ÿ%

ğ‘…ğœ™ğœ‹(1 âˆ’ ğ›¾)ğœ‡&./ ğ‘†" + ğ›¼ğ‘…ğœ™ğœ‹(1 âˆ’ ğ›¾)ğœ‡./ ğ‘†"
ğ‘…ğœ™ğ›¾ğœ‡&./ ğ‘†" + ğ›¼ğ‘…ğœ™ğ›¾ğœ‡./ ğ‘†"
(1 âˆ’ ğ›¾)ğœ‹
=
.
ğ›¾
=

(4)

We re-write this as
ğ›¾=

ğœ‹
.
ğ‘Ÿ% + ğœ‹

(5)

We also expand ğ‘Ÿ( (the ratio of de novo cases versus detected cases that were contacts and
under surveillance) as ?

ğ‘Ÿ(

)%$)0$)%%
),$)-

@. Therefore,

ğ‘…ğœ‹(ğœ‡&' ğ‘†" + (1 âˆ’ ğœ™)ğœ‡&./ ğ‘†" + ğ›¼(1 âˆ’ ğœ™)ğœ‡./ ğ‘†" )
R(ğœ™ğ›¾ğœ‡&./ ğ‘†" + ğ›¼ğœ™ğ›¾ğœ‡./ ğ‘†" )
ğœ‹(ğ›½ + (1 âˆ’ ğœ™))
=
,
ğœ™ğ›¾
=

7

(6)

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

nth generation

n + 1 generation

1

"

!

2

1âˆ’"
&
!

%

1âˆ’&

"
1âˆ’"
"

3
4
5
6

1âˆ’%

7

1âˆ’"
&
'!

%
1âˆ’&

"
1âˆ’"
"

1âˆ’%
1âˆ’"

ND: Case not detected

8
9
10
11
12

NAS: Detected case not under active surveillance
AS: Detected case under active surveillance

Figure 1: Potential pathways for a three-state model of Ebola surveillance (ND, AS, NAS). ğ‘… is the
effective reproduction number, ğ›¼ is the scaling of the reproduction number due to active
surveillance (rapid isolation upon symptom onset), ğœ™ is the proportion of contacts recalled and
reported by a case, ğ›¾ is the proportion of contacts actively under surveillance, and ğœ‹ is the
proportion of cases detected or â€œre-capturedâ€ by community surveillance. We assume that all cases
under active surveillance are detected. The colouring and shape of the end points of the paths are
described as follows: red circle - any case that was not detected (so cannot be under active
surveillance), purple circle - an eventually detected case that was not under active surveillance at
the time of symptom onset (e.g. a contact of an earlier case lost to follow-up or who refused followup), purple square: a detected case that was under active surveillance at the time of symptom onset
(e.g. a contact of a previously detected case, correctly recalled and reported, and under
surveillance).

8

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

where ğ›½ = 1

1'(
')* $21)*

. This can be rewritten as

ğœ‡&' = ğœˆ(ğœ‡&./ + ğ›¼ğœ‡./ ), ğœˆ =

ğ‘Ÿ( ğœ™ğ›¾
âˆ’ 1 + ğœ™.
ğœ‹

(7)

Figure 2 illustrates the dependencies between these two ratios and the parameters in our
model in a directed acyclic graph where the green nodes are our data, blue nodes are model
parameters and white nodes are calculated parameters.

In addition to equations (5) and (7), we also have three more relationships that we can use
to parameterize our NGM: the proportions of each type of case (ğœ‡&' , ğœ‡&./ and ğœ‡./ ) that
are found using the leading eigenvector of the NGM (see SIA). We therefore have five
equations and seven unknown parameters (ğœ‹, ğ›¼, ğœ™, ğ›¾, ğœ‡&' , ğœ‡&./ , ğœ‡./ ). If we fix two, we
can derive estimates of the five remaining parameters. For example, if we fix ğœ‹ and ğœ™, we
can then estimate ğ›¾ directly from equation 5. As shown by the derivation in SIA, the
parameters ğœ‡&' , ğœ‡&./ and ğœ‡./ are defined as a function of ğ›¼, the scaling on the level of
transmission when under surveillance (ğ›¼ = 0 perfect control and ğ›¼ = 1 no impact of
surveillance on transmission). Equation 7 also expresses ğœ‡&' as a function of ğ›¼, ğœ‡&./ and
ğœ‡./ (the proportions of the two contact traced groups). By replacing ğœ‡&./ and ğœ‡./ by their
eigenvector relationships, we can express ğœ‡&' as a function of ğ›¼ only. Therefore, the
system can be solved finding the intersection of the (ğ›¼, ğœ‡% ) curves defined by the two
equations derived from the normalized eigenvector solution for ğœ‡% and equation 7, see SIB
for a graphical example.
Application to the estimation of the proportion of cases that were not detected to two case
studies
SARS-CoV-2 in New Zealand 2020. Well performing contact tracing systems have been
partially credited for the success of the New Zealandâ€™s (NZ) response to the SARS-CoV-2
epidemic in 2020 (23â€“25). NZâ€™s Ministry of Health reported 570 locally acquired cases up

9

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Figure 2: Directed acyclic graph showing the functional relationships of the surveillance model and
the ratios observed in the surveillance. The blue nodes represent the parameters of the model that
we want to infer (ğœ‹ is the proportion of cases detected or â€œre-capturedâ€ by community surveillance;
ğ›¾ is the proportion of contacts actively under surveillance; ğœ™ is the proportion of contacts recalled
by a case and ğ›¼ is the scaling of reproduction number due to active surveillance (rapid isolation
upon symptom onset)). The green terminal nodes are the potentially observable data (ğ‘Ÿ! is the ratio
of cases who were contacts but not under surveillance versus the cases who were contacts and under
surveillance; and ğ‘Ÿ" as the ratio of de novo cases versus detected cases that were contacts and under
surveillance. The white nodes are our calculated terms (ğœ‡#$ is the proportion of cases that are not
detected; and ğœˆ relates the proportion of not detected cases to the other two types of cases). The
arrows show the direction of the dependence.

until 14th December 2020 that had an epidemiological link to a previous case and 90 cases
without an epidemiological link (26). We assume that 80% of contacts were under active
surveillance, since this was determined as the minimum requirement for the NZ system
(22). Therefore, we estimate 456 cases were under active surveillance and 114 cases were
not. This makes ğ‘Ÿ% = 0.25 and ğ‘Ÿ( = 0.20.

10

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Ebola in Guinea 2014 We use data from Dixon et al. (27), which present contact tracing
outcomes from two prefectures in Guinea between the 20th September and 31st December
2014. The authors found that only 45 cases out of 152 were registered as contacts of known
cases across Kindia and Faranah prefectures.
Since there is little published data, we consider two scenarios based on different
assumptions about ğ‘Ÿ% (ratio of contacts not under active surveillance versus contacts under
active surveillance).
1) We assume ğ‘Ÿ% is equal to 0.2 (five times as many contacts under active surveillance
than not under active surveillance, or 5 out of 6 contacts are under active
surveillance). This is based on data from Liberia in 2014 and 2015 where, during
the same epidemic as Guinea, 27936 contacts were not under active surveillance,
whereas 167419 were (28). Since we know the total number of cases on the contact
tracing list, 45, and assume ğ‘Ÿ% = 0.2, we estimate the number of contacts under
active surveillance to be 38 (denominator of ğ‘Ÿ( ). The number of people not on the
contact list for the two regions was 107 (numerator of ğ‘Ÿ( ). Therefore, ğ‘Ÿ( is equal to
2.85.
2) We assume ğ‘Ÿ% is equal to 0.5 (twice as many contacts under active surveillance than
not under active surveillance or two thirds of contacts are under active surveillance)
to illustrate the impact of a slightly better surveillance system. Since we know the
total number of cases on the contact tracing list, 45, and assume ğ‘Ÿ% = 0.5, we
estimate the number of contacts under active surveillance to be 30 (denominator of
ğ‘Ÿ( ). Therefore, ğ‘Ÿ( is equal to 3.57.
We estimated the proportion of cases that are not detected using a quasi-Bayesian
framework for both case studies. We sampled 100,000 values from [0,1]( uniformly for
(ğœ‹, ğœ™), which is comparable to assuming a uniform prior distribution, and computed the
other parameters (ğ›¾, ğ›¼, ğœ‡&' ) if a solution was viable. We note that there is no solution for
some values of (ğœ‹, ğœ™), (see SIB). Since we found our viable parameter space to be convex,
11

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

the mean parameter values calculated from our sampling may be a poor central estimate.
Therefore, we define our central estimate as the solution for the point in our viable
parameter space (ğœ‹, ğœ™) that is furthest from the boundary of our central region. We
calculate this using the polylabelr R package (29). Our credible intervals reflect the values
between which 95% of our viable samples lie. All code necessary to implement the analysis
is included open source in the â€œMissingCasesâ€ R package on GitHub (30).

RESULTS
SARS-CoV-2 in New Zealand 2020. In Figure 3, we find that the region of feasible
parameter space for SARS-CoV-2 was only 2.4% of the total space, which suggests high
certainty in our parameter estimates. It is also located in the top right corner of the
parameter space, where both the proportion of cases detected in the community( ğœ‹) and
proportion of contacts (ğœ™) are high. This suggests a well-functioning and rigorous contact
tracing and surveillance system in NZ, which our estimate that only 6.14% (95% CrI: 1.31 16.7%) of cases are not detected also suggests. All parameter estimates for this model are
given in Table 1.

Ebola in Guinea 2014. We find that our two assumptions for ğ‘Ÿ% result in different feasible
parameter spaces, which overlap at high values (>75%) of the proportion of cases detected
in the community (ğœ‹), see Figure 4. The feasible region was again small for Scenario 1
when ğ‘Ÿ% = 0.2 was 5.4% of the region [0,1]( and 4.3% for Scenario 2 when ğ‘Ÿ% = 0.5. Our
estimates of the proportion of Ebola cases that were not detected in Guinea was 64.5%
(95% CrI: 15.5-89.3%) or 63.3% (95% CrI 15.9 â€“ 83.0%) for our two scenarios where ğ‘Ÿ% =
0.2 and ğ‘Ÿ% = 0.5 respectively. These estimates are not significantly different despite our
two assumptions. The corresponding model parameter estimates for both scenarios are
given in Table 2. The only parameter that differs significantly between our scenario is the
12

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Proportion of contacts recalled ( f )

100%

75%

50%

25%

0%
0%

25%

50%

75%

Proportion of cases detected in the community ( p )

100%

Figure 3: Region of the parameter space compatible with the observed data New Zealand. Values of
ğœ‹ and ğœ™ are sampled uniformly from [0,1]" in all cases. The blue dots show our feasible samples
and the red dots indicate the point inside each polygon that is most distant from the outline.

Table 1: Estimates of the parameters for SARS-CoV-2 in New Zealand
Parameter

Description

Central estimates (95% CrI)

ğœ‹

Proportion of cases detected in the community

82.5% (60.6, 95.9)

ğ›¼

Scaling of the reproduction number for traced cases

30.8% (2.39, 97.5)

ğœ™

Proportion of contacts recalled

95.1% (87.9, 99.8)

ğ›¾

Proportion of contact under active surveillance

76.8% (70.8, 79.3)

ğœ‡!"

Proportion of cases not detected

6.14% (1.31, 16.7)

13

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

100%

75%

Proportion of contacts recalled ( f )

Percentage of contacts recalled ( f )

100%

75%

50%
50%

25%
25%

0% 0%
0% 0%

25%
25%

50%
50%

75%
75%

100%
100%

Percentage
detectedininthe
the
community
Proportionof
ofcases
cases detected
community
( p )( p )
rr11

0.2
0.2

0.5
0.5

Figure 4: Region of the parameter space compatible with the observed data for the two scenarios in
Guinea. Values of ğœ‹ and ğœ™ are sampled uniformly from [0,1]" in all cases. The blue dots show the
feasible samples for ğ‘Ÿ! = 0.2 and the purple dots for ğ‘Ÿ! = 0.5. The red dots indicate the point
inside each polygon that is most distant from the outline.

Table 2: Estimates of the parameters for Ebola in Guinea
Central estimates (95% CrI)
Parameter
ğ‘Ÿ&

Description
Ratio of de novo cases versus detected cases that
were contacts and under surveillance

ğœ‹

Proportion of cases detected in the community

ğ›¼

Scaling of the reproduction number for traced
cases

Scenario 1 (ğ‘Ÿ+ = 0.2)

Scenario 2 (ğ‘Ÿ+ = 0.5)

2.85

3.57

29.3% (8.26, 80.4)

31.7% (14.1, 81.0)

44.3% (2.06, 96.9)

47.9% (2.17, 97.3)

ğœ™

Proportion of contacts recalled

45.8% (31.4, 95.3)

54.5% (32.4, 97.1)

ğ›¾

Proportion of contact under active surveillance

59.4% (29.2, 80.1)

38.8% (22.1, 61.8)

ğœ‡!"

Proportion of cases not detected

64.5% (15.5, 89.3)

63.3% (15.9, 83.0)

14

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

proportion of contact under active surveillance, which is directly impacted by the ratio of
contacts not under active surveillance versus contacts under active surveillance.

DISCUSSION
Contact tracing is an important control mechanism for infectious disease outbreaks.
However, its efficiency depends on detecting as many cases as possible. We show in this
paper that NGMs can be easily used to estimate the proportion of cases that were not
detected for two different disease outbreaks. Our method requires much less data (only 5
parameters) that other methods, such as capture re-capture (10), which is an alternative
method suggested for estimating under-reporting and is highly data intensive. This means
that it is feasible to repeat this analysis in near real time as the epidemic unfolds.
During the West African Ebola epidemic, the WHO acknowledged that their reported case
and death figures â€œvastly underestimate(d)â€ the true magnitude of the epidemic (31). We
find that our estimates for the proportion of cases not detected in Guinea (64.5% (95% CrI:
15.5-89.3%) or 63.3% (95% CrI 15.9 â€“ 83.0%) for our two scenarios where ğ‘Ÿ% = 0.2 and
ğ‘Ÿ% = 0.5 respectively) are in line with values in the literature for neighbouring countries.
The US Centers for Disease Control and Prevention (32) estimated a 40% reporting rate
(60% under-reporting) from Ebola treatment unit bed data and Gignoux et al. (33)
estimated a 33% (67% under-reporting) from a capture and recapture study in Liberia
between June and August 2014. However, Dalziel et al. (9) suggested higher reporting rates
in Sierra Leone, for example 68% (32% under reporting) in the Western Area Urban on 20
October 2014 using burial data.
Our estimates of the proportion of cases that were not detected during the SARS-Cov-2
outbreak in NZ of 6.14% (95% CrI 1.31 - 16.7) is in-line with the good health care facilities
and the low community transmission of COVID-19 in NZ (26), but we did not find any
estimates in literature to compare our estimates to.

15

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

A benefit of this method is that we do not just estimate the proportion of cases that were not
detected but also other useful quantities that are important for managing a response such as
the proportion of cases that are detected in the community. Our central estimates for routine
surveillance of 82.5% (95% CrI: 60.6 â€“ 95.9%) suggests that NZ was very effective at
detecting cases in the community during the SARS-Cov-2 outbreak. In contrast, our
estimates of 29.3% (95% CrI: 8.26-80.4%) and 31.7% (95% CrI 14.1-81.0%) suggests that
routine surveillance could have been an area for improvement during the West African
Ebola outbreak in Guinea. We also find that a higher proportion of contacts were recalled,
or membered, in the NZ SARS-Cov-2 outbreak 95.1% (95% CrI: 87.9-99.8%) compared to
the Ebola epidemic in Guinea (45.8% (95% CrI: 31.4-95.3%) and 54.5% (95% CrI: 32.497.1%)). This could reflect more trust in the NZ health service. The wide credible intervals
come from the uniform sample of (ğœ‹, ğœ™). This is a limitation of the method but could be
improved with more information about the numbers of contacts people had (ğœ™) and a better
understanding of the performance of the routine surveillance (ğœ‹) to narrow the region.
We believe this method highlights important lessons for responding to the ongoing SARSCoV-2 pandemic and the unfortunate inevitability of future infectious disease outbreaks. By
simply linking the case line-lists and contact tracing lists, we can use the very general
method from our â€œMissingCasesâ€ package (30) to assess under-reporting throughout an
epidemic. This would help outbreak responses, especially during the early and late phases,
target resources and quantify how effect their surveillance systems were. In addition, these
estimates can be used to improve the accuracy of other models, such as for the time varying
reproduction number, which are key tools for the outbreak response themselves.

REFERENCES
1.

SalathÃ© M, Althaus CL, Neher R, Stringhini S, Hodcroft E, Fellay J, et al. COVID19 epidemic in Switzerland: On the importance of testing, contact tracing and
isolation. Swiss Med Wkly [Internet]. 2020 Mar 19 [cited 2020 Dec 10];150(11â€“12).

16

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Available from: https://doi.emh.ch/smw.2020.20225
2.

Saurabh S, Prateek S. Role of contact tracing in containing the 2014 Ebola outbreak:
a review. Afr Health Sci [Internet]. 2017 Mar [cited 2020 Dec 10];17(1):225â€“36.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29026397

3.

LÃ³paz MA, Amela C, Ordobas M, DomÃ­nguez-BerjÃ³n MF, Ãlvarez C, MartÃ­nez M,
et al. First secondary case of Ebola outside Africa: epidemiological characteristics
and contact monitoring, Spain, September to November 2014. Eurosurveillance
[Internet]. 2015 Jan 8 [cited 2020 Dec 10];20(1):21003. Available from:
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES2015.20.1.21003

4.

Smith CL, Hughes SM, Karwowski MP, Chevalier MS, Hall E, Joyner SN, et al.
Addressing needs of contacts of Ebola patients during an investigation of an Ebola
cluster in the United States - Dallas, Texas, 2014. [Internet]. Vol. 64, MMWR.
Morbidity and mortality weekly report. 2015 [cited 2020 Dec 10]. p. 121â€“3.
Available from:
http://www.ncbi.nlm.nih.gov/pubmed/25674993%0Ahttp://www.pubmedcentral.nih.
gov/articlerender.fcgi?artid=PMC4584687

5.

Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented
infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).
Science (80- ) [Internet]. 2020 May 1 [cited 2020 Dec 10];368(6490):489â€“93.
Available from: https://science.sciencemag.org/content/368/6490/489

6.

Gamado KM, Streftaris G, Zachary S. Modelling under-reporting in epidemics. J
Math Biol. 2014;69(3):737â€“65.

7.

Adalja AA, Toner E, Inglesby T V. Priorities for the US Health Community
Responding to COVID-19. JAMA [Internet]. 2020 Apr 14 [cited 2020 Dec
10];323(14):1343. Available from:
https://jamanetwork.com/journals/jama/fullarticle/2762690

8.

Lavezzo E, Franchin E, Ciavarella C, Cuomo-Dannenburg G, Barzon L, Del Vecchio
C, et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Voâ€™.
Nature [Internet]. 2020 Aug 20 [cited 2020 Dec 10];584(7821):425â€“9. Available

17

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

from: http://www.nature.com/articles/s41586-020-2488-1
9.

Dalziel BD, Lau MSY, Tiffany A, McClelland A, Zelner J, Bliss JR, et al.
Unreported cases in the 2014-2016 Ebola epidemic: Spatiotemporal variation, and
implications for estimating transmission. PLoS Negl Trop Dis.
2018;12(1):e0006161.

10.

Enserink M. How many Ebola cases are there really? Sci Now [Internet]. 2014;4.
Available from:
http://search.ebscohost.com/login.aspx?direct=true&db=a2h&AN=99172119&site=e
host-live

11.

Rivers C, Chretien J-P, Riley S, Pavlin JA, Woodward A, Brett-Major D, et al. Using
â€œoutbreak scienceâ€ to strengthen the use of models during epidemics. Nat Commun
[Internet]. 2019 Dec 15 [cited 2020 Dec 10];10(1):3102. Available from:
http://www.nature.com/articles/s41467-019-11067-2

12.

Enserink M, Kupferschmidt K. Mathematics of life and death: How disease models
shape national shutdowns and other pandemic policies. Science (80- ) [Internet].
2020 Mar 25 [cited 2020 Dec 10]; Available from:
https://www.sciencemag.org/news/2020/03/mathematics-life-and-death-howdisease-models-shape-national-shutdowns-and-other

13.

Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al.
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.
Nature [Internet]. 2020 Aug 13 [cited 2020 Dec 10];584(7820):257â€“61. Available
from: http://www.nature.com/articles/s41586-020-2405-7

14.

Ferguson NM, Laydon D, Nedjati-Gilani G, Imai N, Ainslie K, Baguelin M, et al.
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19
mortality and healthcare demand. 2020 [cited 2020 Dec 10]; Available from:
https://doi.org/10.25561/77482.

15.

Xia Z-Q, Wang S-F, Li S-L, Huang L-Y, Zhang W-Y, Sun G-Q, et al. Modeling the
transmission dynamics of Ebola virus disease in Liberia. Sci Rep [Internet]. 2015
Nov 8 [cited 2020 Dec 11];5(1):13857. Available from:

18

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

http://www.nature.com/articles/srep13857
16.

Heesterbeek JAP, Dietz K. The concept of R o in epidemic theory. Stat Neerl
[Internet]. 1996 Mar 1 [cited 2020 Dec 11];50(1):89â€“110. Available from:
http://doi.wiley.com/10.1111/j.1467-9574.1996.tb01482.x

17.

Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, et al.
Estimating the Future Number of Cases in the Ebola Epidemic â€” Liberia and Sierra
Leone, 2014â€“2015 [Internet]. MMWR. Morbidity and mortality weekly report. 2014
[cited 2020 Dec 11]. Available from: http://stacks.cdc.gov/view/cdc/24900

18.

Diekmann O, Heesterbeek JAP, Metz JAJ. On the definition and the computation of
the basic reproduction ratio R0 in models for infectious diseases in heterogeneous
populations. J Math Biol. 1990;28(4):365â€“82.

19.

Diekmann O, Heesterbeek JAP, Roberts MG. The construction of next-generation
matrices for compartmental epidemic models. J R Soc Interface. 2010;7(47):873â€“85.

20.

WHO. EMERGENCY GUIDELINE Implementation and management of contact
tracing for Ebola virus disease [Internet]. 2015 [cited 2020 Dec 10]. Available from:
https://apps.who.int/iris/bitstream/handle/10665/185258/WHO_EVD_Guidance_Co
ntact_15.1_eng.pdf;jsessionid=1BA73A77042B8EA4BE60F9A971E37D46?sequen
ce=1

21.

NHS. If youâ€™re told to self-isolate by NHS Test and Trace - NHS [Internet]. 2020
[cited 2020 Dec 10]. Available from: https://www.nhs.uk/conditions/coronaviruscovid-19/testing-and-tracing/nhs-test-and-trace-if-youve-been-in-contact-with-aperson-who-has-coronavirus/

22.

Verrall A. Rapid Audit of Contact Tracing for Covid-19 in New Zealand [Internet].
2020 [cited 2020 Dec 14]. Available from:
https://apo.org.au/sites/default/files/resource-files/2020-04/apo-nid303350.pdf

23.

Baker MG, Kvalsvig A, Verrall AJ, Telfar-Barnard L, Wilson N. New Zealandâ€™s
elimination strategy for the COVID-19 pandemic and what is required to make it
work [Internet]. Vol. 133, New Zealand Medical Journal. 2020 [cited 2020 Dec 14].
p. 10â€“4. Available from: https://www.nzma.org.nz/journal-articles/new-zealands-

19

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

elimination-strategy-for-the-covid-19-pandemic-and-what-is-required-to-make-itwork
24.

Jefferies S, French N, Gilkison C, Graham G, Hope V, Marshall J, et al. COVID-19
in New Zealand and the impact of the national response: a descriptive
epidemiological study. Lancet Public Heal [Internet]. 2020 [cited 2020 Dec
14];5(11):e612â€“23. Available from: www.thelancet.com/

25.

James A, Plank MJ, Hendy S, Binny R, Lustig A, Steyn N, et al. Successful contact
tracing systems for COVID-19 rely on effective quarantine and isolation 4 August
2020. [cited 2020 Dec 14]; Available from:
https://doi.org/10.1101/2020.06.10.20125013

26.

New Zealand Ministry of Health. COVID-19: Souce of cases. 2020.

27.

Dixon MG, Taylor MM, Dee J, Hakim A, Cantey P, Lim T, et al. Contact Tracing
Activities during the Ebola Virus Disease Epidemic in Kindia and Faranah, Guinea,
2014 - Volume 21, Number 11â€”November 2015 - Emerging Infectious Diseases
journal - CDC. [cited 2020 Dec 14]; Available from:
https://wwwnc.cdc.gov/eid/article/21/11/15-0684_article

28.

Swanson KC, Altare C, Wesseh CS, Nyenswah T, Ahmed T, Eyal N, et al. Contact
tracing performance during the Ebola epidemic in Liberia, 2014-2015. Althouse B,
editor. PLoS Negl Trop Dis [Internet]. 2018 Sep 12 [cited 2020 Dec
14];12(9):e0006762. Available from:
https://dx.plos.org/10.1371/journal.pntd.0006762

29.

Larsson J. polylabelr: Find the pole of inaccessibility (visual center) of a polygon
[Internet]. 2020. Available from: https://github.com/jolars/polylabelr

30.

Unwin HJT, Baguelin M. MissingCases. 2020;

31.

WHO. No early end to the Ebola outbreak. 2014.

32.

Centers for Disease Control and Prevention (CDC). Updating the Estimates of the
Future Number of Cases in the Ebola Epidemicâ€”Liberia, Sierra Leone, and Guinea,
2014â€“2015 | Ebola (Ebola Virus Disease) | CDC [Internet]. 2020 [cited 2020 Dec
15]. Available from: https://www.cdc.gov/vhf/ebola/outbreaks/2014-west-

20

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

africa/estimating-future-cases/december-2014.html
33.

Gignoux E, Idowu R, Bawo L, Hurum L, Sprecher A, Bastard M, et al. Use of
Captureâ€“Recapture to Estimate underreporting of Ebola Virus disease, Montserrado
County, Liberia [Internet]. Vol. 21, Emerging Infectious Diseases. 2015 [cited 2020
Dec 15]. p. 2265â€“7. Available from: http://wwwnc.cdc.gov/eid/article/21/12/150756_article.htm

ACKNOWLEDGEMENTS
All authors acknowledge funding from the MRC Centre for Global Infectious Disease Analysis
(reference MR/R015600/1), jointly funded by the UK Medical Research Council (MRC) and the
UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat
agreement and is also part of the EDCTP2 programme supported by the European Union; and
acknowledge funding by Community Jameel. HJTU also acknowledges funding from Imperial
College, London for her fellowship. CAD also acknowledge the NIHR Health Protection Research
Unit in Emerging and Zoonotic Infections.

21

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Using next generation matrices to estimate the proportion of cases that
are not detected in an outbreak Supplementary Information
Supplementary Information A: Convergence of the surveillance system
Here we derive the proportion cases that are undetected using a framework where the
proportion of cases that are not detected does not directly depend on the values of the
reproduction number, ğ‘…. Following on from equation 1, we re-write
"

ğ‘" = K ğ‘… ğµğ‘! ,

(ğ‘†1)

34!

where if we assume ğœ‰ = ğ›¾ğœ™,
1âˆ’ğœ‹
ğµ=8 ğœ‹
0

(1 âˆ’ ğœ‹)(1 âˆ’ ğœ‰)
ğœ‹(1 âˆ’ ğœ‰)
ğœ‰

ğ›¼(1 âˆ’ ğœ‹)(1 âˆ’ ğœ‰)
ğ›¼ğœ‹(1 âˆ’ ğœ‰) ; .
ğ›¼ğœ‰

(ğ‘†2)

Assuming ğµ is diagonalisable, we can rewrite equation S2 as:
1 0
â¡
ğœ†(
â¢0
ğœ†%
ğµ = ğœ†% ğ‘ƒ â¢
â¢0 0
â£

0

â¤
0 â¥ 5%
â¥ğ‘ƒ
ğœ†, â¥
ğœ†% â¦

(ğ‘†3)

where Î» denote eigenvalues of which ğœ†% is the biggest, and
ğ‘
ğ‘ƒ = Xğ‘
ğ‘

ğ‘‘
ğ‘’
ğ‘“

ğ‘”
â„b ,
ğ‘–

(ğ‘†4)

is the matrix composed of the eigenvectors [ğ‘, ğ‘, ğ‘]âŠº , [ğ‘‘, ğ‘’, ğ‘“]âŠº and [ğ‘”, â„, ğ‘–]âŠº in order of
descending eigenvalues. Following this decomposition, the evolution of the system can be
rewritten as:
22

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

1
0
"
â¡
ğœ†
"
â¢0 c ( d
ğœ†%
ğ‘" = ğœ†%" K ğ‘… ğ‘ƒ â¢
â¢
34!
â¢0
0
â£

0

â¤
0 â¥ 5%
â¥ ğ‘ƒ ğ‘! .
"â¥
ğœ†,
c d â¥
ğœ†% â¦

(ğ‘†5)

We define
ğ‘—
Xğ‘˜b = ğ‘ƒ5% ğ‘!
ğ‘™

(ğ‘†6)

as the vector of the initial conditions in the coordinate system defined by the ğ‘ƒ5% matrix.
Therefore, we can re-write equation S5 as

ğ‘"

1
0
"
â¡
ğœ†
"
â¢0 c ( d
ğœ†%
= ğœ†%" K ğ‘… ğ‘ƒ â¢
â¢
34!
â¢0
0
â£
ğ‘—
â¡
" â¤
"
â¢cğœ†( d ğ‘˜ â¥
â¥.
= ğœ†%" K ğ‘… ğ‘ƒ â¢ ğœ†%
â¢
" â¥
34!
â¢ cğœ†, d ğ‘™ â¥
â£ ğœ†%
â¦

0

â¤
0 â¥ ğ‘—
â¥ Xğ‘˜ b ,
"â¥
ğœ†,
ğ‘™
c d â¥
ğœ†% â¦

(ğ‘†7)

This means we can define the number of each type of case (ND, NAS and AS) in generation
ğ‘› as

23

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

"

ğ‘ğ·"

ğœ†( "
ğœ†, "
= hğ‘ğ‘— + ğ‘‘ğ‘˜ c d + ğ‘”ğ‘™ c d i ğœ†%" K ğ‘… ,
ğœ†%
ğœ†%
"

ğ‘ğ´ğ‘†"

34!
"

ğœ†(
ğœ†,
= hğ‘ğ‘— + ğ‘’ğ‘˜ c d + â„ğ‘™ c d i ğœ†%" K ğ‘… ,
ğœ†%
ğœ†%
"

ğ´ğ‘†"

"

"

34!
"

ğœ†(
ğœ†,
= hğ‘ğ‘— + ğ‘“ğ‘˜ c d + ğ‘–ğ‘™ c d i ğœ†%" K ğ‘… .
ğœ†%
ğœ†%
34!

and the proportion of missing cases
ğ‘ğ·"
ğ‘ğ·" + ğ‘ğ´ğ‘†" + ğ´ğ‘†"
ğœ† "
ğœ† "
ğ‘ğ‘— + ğ‘‘ğ‘˜ j ( k + ğ‘”ğ‘™ c , d
ğœ†%
ğœ†%
=
.
"
ğœ†(
ğœ†, "
ğ‘—(ğ‘ + ğ‘ + ğ‘) + ğ‘˜(ğ‘‘ + ğ‘’ + ğ‘“) jğœ† k + ğ‘™(ğ‘” + â„ + ğ‘–) cğœ† d
%
%
"

7

(ğ‘†8)

"

7

As j7, k < 1 and j7.k < 1 by construction, we have:
-

-

ğ‘ğ·"
ğ‘
=
= ğœ‡&'
"â†’9 ğ‘ğ·" + ğ‘ğ´ğ‘†" + ğ´ğ‘†"
ğ‘+ğ‘+ğ‘
lim

where [ğ‘, ğ‘, ğ‘]âŠº is the eigenvector associated with the biggest eigenvalue of ğµ. This
eigenvector can be found by calculating the determinant of ğµ âˆ’ ğœ†ğ¼, were ğ¼ is the 3x3
identity matrix.
The largest eigenvalue of B is equal to
1
j1 âˆ’ ğœ‹ğœ‰ + ğ›¼ğœ‰ + o(âˆ’1 + ğœ‹ğœ‰ âˆ’ ğ›¼ğœ‰)( âˆ’ 4(ğ›¼ğœ‰ âˆ’ ğœ‹ğ›¼ğœ‰)k
2
and corresponds to the eigenvector

24

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

( (
(
â¡(âˆ’1 + ğœ‹) âˆ’1 + ğœ‹ğœ‰ + ğ›¼ğœ‰ âˆ’ oâˆ’2ğœ‹(1 + ğ›¼(âˆ’2 + ğœ‰))ğœ‰ + ğœ‹ ğœ‰ + (âˆ’1 + ğ›¼ğœ‰) )â¤
2ğœ‹ğœ‰
â¢
â¥
â¢
â¥.
1 âˆ’ ğœ‹ğœ‰ âˆ’ ğ›¼ğœ‰ + oâˆ’2ğœ‹(1 + ğ›¼(âˆ’2 + ğœ‰))ğœ‰ + ğœ‹ ( ğœ‰ ( + (âˆ’1 + ğ›¼ğœ‰)(
â¢
â¥
â¢
â¥
2ğœ‰
â£
â¦
1

Therefore,
ğœ‡&'
=

(âˆ’1 + ğœ‹)(1 + ğ›¼(âˆ’2 + ğœ‰) âˆ’ ğœ‹ğœ‰ + oâˆ’2ğœ‹(1 + ğ›¼(âˆ’2 + ğœ‰))ğœ‰ + ğœ‹ ( ğœ‰]( + (âˆ’1 + ğ›¼ğœ‰)( )
.
2(ğ›¼ âˆ’ 1)

We now show an example of the convergence of the system. We assume ğœ‹ = 0.83, ğ›¼ =
0.30, ğ›¾ = 0.77 and ğœ™ = 0.95. We chose a distribution for ğ‘… to get some variability while
keeping a relatively contained epidemic.
ğ‘… âˆ¼ ğ’°(0.2,2)
B 1.00

A

Proportion of not detected cases

Number of cases recorded

3000

2000

1000

0

10

20

30

40

50

Generations

0.75

0.50

0.25

0.00

10

20

30

40

50

Number of generations

Figure S1: Evolution of simulated outbreak. A) Number of cases for each generation of the example model
where ğœ‹ = 0.83, ğ›¼ = 0.30, ğ›¾ = 0.77, ğœ™ = 0.95 and ğ‘… âˆ¼ ğ’°(0.2,2). B) Proportion of not detected cases over

25

(ğ‘†9)

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a number of generations. The black dots are values derived from simulation while the red line shows the value
derived analytically.

We see that, as predicted by the analytic derivation, despite the unpredictable course of the
epidemics (Figure S1A), the proportion of missing cases quickly reaches an equilibrium
(Figure S1B). This proportion at equilibrium can be calculated using the formula derived
above. We note that the convergence is exponential and thus fast proving that ğœ†% â‰« ğœ†( and
ğœ†% â‰« ğœ†, .

Supplementary Information B: Solution of the system of equations assuming parameters
We assume that ğœ‹ = 0.83, ğœ™ = 0.95 and get ğ‘Ÿ% = 0.25 and ğ‘Ÿ( = 0.20 from the NZ data.
Using Equation 5, we estimate ğ›¾ = 0.77. Solving the system gives the following solution:
ğ›¼ = 0.30 and ğœ‡% = 0.06 meaning that in this configuration, 6% of the cases are not detected
and missing from the records. A graphical representation is given in Figure S2, where the
solution of the system can be seen at the intersection of the two curves. No solution is
found if the two curves do not intersect.

26

medRxiv preprint doi: https://doi.org/10.1101/2021.02.24.21252339; this version posted February 26, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Proportion of not detected cases ( ÂµND )

100%

75%

Equation 7

50%

NGM

25%

0%
0%

25%

50%

75%

Scaling of reproduction number ( a )

100%

Figure S2: Derivation of ğ›¼ the scaling of the reproduction number following contactt tracing and ğœ‡+ the
proportion of not detected cases, assuming ğœ‹ = 0.82 and ğœ™ = 0.95. The solid line links ğœ‡ and ğ›¼ by using the
proportion of de novo cases observed vs cases who are contact and followed up. The dashed line indicates the
relationship given by the dynamics of the next generation model.

27

